Serum Activity of Platelet-Activating Factor Acetylhydrolase Is a Potential Clinical Marker for Leptospirosis Pulmonary Hemorrhage
Junwei Yang, Yixuan Zhang, Jing Xu et al. · 2009
Read Serum Activity of Platelet-Activating Factor Acetylhydrolase Is a Potential Clinical Marker for Leptospirosis Pulmonary Hemorrhage by Junwei Yang, Yixuan Zhang, Jing Xu et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004181.txt.
Description
Junwei Yang and colleagues published this infection study in PLOS ONE in 2009. Bleeding in the lungs is a major and often deadly feature of severe leptospirosis. Leptospirosis is a bacterial infection caught from animal-contaminated water, and the cause of its lung bleeding is unclear. The dangerous serovar Lai of Leptospira interrogans makes a protein that acts on platelet-activating factor, a blood signal.
Following that clue, the team measured the activity of the matching enzyme, PAF acetylhydrolase, in patients' blood. They propose its serum activity as a possible clinical marker for the lung bleeding form of the disease. An early warning marker could help doctors spot the patients most at risk.
Catalog record
| CREATOR | Junwei Yang, Yixuan Zhang, Jing Xu et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004181